Please assess the completion status of the following clinical trial:

Trial Title: Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Heart transplantation~* LVAD placement~* Lung Transplantation~Exclusion Criteria:~* Combined Organ Transplantation~* Age \< 18 years old~* Pregnancy~* Known allergy to prostaglandin (rare)~* Refusal of blood products due to personal or religious preference~* Subject is enrolled in another study protocol, which does not allow randomization of PVD therapy~* Heart transplant or durable LVAD recipients with adult congenital heart disease (CHD)~  o Caveat: Does NOT meet exclusion criteria if the scheduled heart transplant or LVAD implantation is due to heart failure from a previous heart transplantation related to CHD, performed more than 90 days previous to the date of trial enrollment~* Heart transplant recipients diagnosed with Arrythmogenic Right Ventricular Cardiomyopathy~* Heart transplant recipients diagnosed with Acute Cardiac Allograft Rejection after a previous heart transplantation.~* Heart transplant or durable LVAD recipients with preoperative RVAD for right heart failure~* Patient is scheduled to undergo lung transplantation but has undergone heart transplantation in the previous 90 days~* Patient is scheduled to undergo durable LVAD implantation but has undergone heart transplantation in the previous 90 days~* Patient is scheduled to undergo heart transplantation but has undergone lung transplantation in the previous 90 days~* Patients with preoperative Venovenous ECMO as a bridge to lung transplantation~* Heart transplant or durable LVAD recipients with preoperative RVAD for right heart failure

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lung transplant with iNO (Type: ACTIVE_COMPARATOR): None
- Lung transplant with iEPO (Type: ACTIVE_COMPARATOR): None
- Heart transplant & LVAD implantation with iNO (Type: ACTIVE_COMPARATOR): None
- Heart transplant & LVAD implantation with iEPO (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).